Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Depression, Major Depression Disorder (MDD) |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/16/2015 |
| Start Date: | October 2012 |
| End Date: | March 2014 |
The current study will test the causal relationship between elevated levels of cortisol and
the serotonin transporter gene (5-HTTLPR) as these factors influence sensitivity to
environmental threat. The investigators predict that carriers of the short allele of the
serotonin transporter gene who have elevated cortisol levels will be most sensitive to
threatening environments, whereas carriers of the long allele who do not have elevated
cortisol (placebo subjects) will be least sensitive.
the serotonin transporter gene (5-HTTLPR) as these factors influence sensitivity to
environmental threat. The investigators predict that carriers of the short allele of the
serotonin transporter gene who have elevated cortisol levels will be most sensitive to
threatening environments, whereas carriers of the long allele who do not have elevated
cortisol (placebo subjects) will be least sensitive.
Depression vulnerability has been linked to certain variants of the serotonin transporter
gene. Research indicates that a polymorphism of the serotonin transporter (5-HTTLPR) gene
appears to moderate the association between life stress and depression onset. Life stress
robustly predicts depression onset for individuals with two short 5-HTTLPR alleles.
Individuals homozygous for the short 5-HTTLPR allele thus appear to be more sensitive to the
effect of life stress, which in turn contributes to depression onset. A recent study showed
that short allele carriers presented with a threat (social or other threats) who also had
high levels of testosterone had elevated cortisol after exposure to the threat. There is
neurobiological evidence that short allele status, elevated testosterone levels, and
elevated cortisol levels are all linked to amygdala hyper-reactivity to the same classes of
environmental threats. Thus, this study will test, for the first time, a potential
interaction between 5-HTTLPR status and experimentally manipulated cortisol levels as risk
factors for downstream mood and/or anxiety disorders by examining potential dysregulated
stress responses among short allele carriers who have elevated cortisol levels.
gene. Research indicates that a polymorphism of the serotonin transporter (5-HTTLPR) gene
appears to moderate the association between life stress and depression onset. Life stress
robustly predicts depression onset for individuals with two short 5-HTTLPR alleles.
Individuals homozygous for the short 5-HTTLPR allele thus appear to be more sensitive to the
effect of life stress, which in turn contributes to depression onset. A recent study showed
that short allele carriers presented with a threat (social or other threats) who also had
high levels of testosterone had elevated cortisol after exposure to the threat. There is
neurobiological evidence that short allele status, elevated testosterone levels, and
elevated cortisol levels are all linked to amygdala hyper-reactivity to the same classes of
environmental threats. Thus, this study will test, for the first time, a potential
interaction between 5-HTTLPR status and experimentally manipulated cortisol levels as risk
factors for downstream mood and/or anxiety disorders by examining potential dysregulated
stress responses among short allele carriers who have elevated cortisol levels.
Inclusion Criteria:
- None
Exclusion Criteria:
- Are you under the age of 18 years old?
- Have you ever had an allergic reaction to hydrocortisone?
- Do you have diabetes or high blood pressure?
- Do you have any thyroid, liver, heart, lung, or kidney problems?
- Do you have herpes, HIV or any sexual transmitted disease?
- Are you currently pregnant or think you might be pregnant? Have you taken RU486,
Plan B or "Morning After Pill" within the last 2 weeks? - Are you currently
breastfeeding?
- Have you been sick within the last week? Do you have any fungal infections?
- Have you been exposed to measles or chicken pox in the last week?
- Have you ever had a seizure?
- Do you have any disease of bony tissue, such as osteoporosis?
- Do you have any autoimmune diseases, such as myasthenia gravis?
- Do you have multiple sclerosis?
- Do you have any condition that compromises you immune system function or causes you
to be more likely to get sick?
- Have you had any recent surgeries?
- Do you have and gastrointestinal problems, such as ulcers, diverticulitis, colitis,
hepatitis, or Crohn disease?
- Are you taking any of the following medications: nevirapine, telbivudine,
sipuleucel-T (IV), natalizumab (IV)?
- Have you received any vaccinations within the last week?
- With the exception of vitamins, have you taken any medications in the last 3 days,
including all over-the counter medications and/or supplements (e,g. Tylenol,
ibuprofen, St. John's Wort, cold remedies)?
- Do you currently have or have you had in the past of any kind of cancer?
- Do you have any significant medical or psychiatric illnesses not listed above?
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials